Delhi HC asks government if it approved Biocon ’s trastuzumab for three cancers
Biosimilars are copies of complex drugs based on living cells. They are different from chemical-based generic drugs, which are 'identical' to the compound used in the original.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Chemistry | Government | Herceptin | Pharmaceuticals